| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |